We are live on
!
Find out more
NTCM
Nine Ten Capital Management Portfolio holdings
AUM
$315M
1-Year Est. Return
62.95%
This Fund
S&P 500
This Quarter
Est. Return
-10.1%
1 Year Est. Return
+62.95%
3 Year Est. Return
+88.95%
5 Year Est. Return
+99.78%
10 Year Est. Return
+1,599.35%
AUM
$316M
AUM Growth
-$42.3M
(-12%)
Cap. Flow
-$1.61M
Cap. Flow
% of AUM
-0.51%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
4
Reduced
3
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HSKA
Heska Corp
HSKA
|
+$19.1M |
| 2 |
StoneX
SNEX
|
+$4.4M |
| 3 |
SI-BONE Inc
SIBN
|
+$1.69M |
| 4 |
iRadimed
IRMD
|
+$471K |
| 5 |
Trupanion
TRUP
|
+$466K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mesa Laboratories
MLAB
|
+$10.8M |
| 2 |
INST
Instructure, Inc.
INST
|
+$9.64M |
| 3 |
Omega Flex
OFLX
|
+$6.66M |
| 4 |
TechTarget
TTGT
|
+$706K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.58% |
| 2 | Consumer Discretionary | 18.77% |
| 3 | Healthcare | 8.31% |
| 4 | Technology | 6.11% |
| 5 | Industrials | 0.8% |
Similar funds
SAMC
KHCM
EP
OIC
WIC
EWA
WA
TF
Nine Ten Capital Management's Q3 2019 Portfolio in Review
As of Q3 2019, Nine Ten Capital Management held 10 positions worth $316M, down 12% from $358M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Nine Ten Capital Management's Q3 2019 filing shows 1 new, 4 increased, 3 reduced and 1 closed positions. Its largest new stake was iRadimed: 23,079 shares worth $485K. The largest sale was Mesa Laboratories, an estimated $10.8M.
By sector, the portfolio is most concentrated in Financials at 34% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Nine Ten Capital Management's largest Q3 2019 buy was iRadimed: 23,079 shares worth $485K.
- Nine Ten Capital Management added most to Heska Corp in Q3 2019, an estimated $19.1M increase.
- Nine Ten Capital Management's biggest Q3 2019 reduction was Instructure, Inc., cutting an estimated $9.64M.
- Nine Ten Capital Management fully exited Mesa Laboratories in Q3 2019, selling an estimated $10.8M.
- Nine Ten Capital Management's ten largest holdings make up 100% of its $316M portfolio in Q3 2019.
- Nine Ten Capital Management opened 1 new position and closed 1 in Q3 2019.
- Nine Ten Capital Management's portfolio value fell 12% quarter-over-quarter to $316M.
Based on Nine Ten Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.